Market Size of Lung Cancer Surgery Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 7.00 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Lung Cancer Surgery Market Analysis
Rising air pollution and people getting affected by it are one of the prime factors responsible for the growth of the market for lung cancer surgery. As per an article by the Vital Strategies Environmental Health Division staff, 2018, while most of the 4.2 million premature deaths linked to air pollution are due to heart disease and strokes, around 1.7 million deaths are from lung cancer and other respiratory diseases globally. According to the WHO database, levels of ultra-fine particles of less than 2.5 microns are highest in India, which has 16 of the world's 30 most polluted cities. Thus, a rise in air pollution is, primarily, driving the lung cancer rate, and hence the studied market is expected to be impacted.
Lung Cancer Surgery Industry Segmentation
Lung cancer is the lethal lung tumor portrayed by the uncontrolled growth of cells in the lung tissues. The interpretation of lung cancer is confirmed by biopsy, which is carried out using bronchoscopy or CT-guidance. Lung cancer surgery is the surgical ablation of cancer tissue from the lung. The type of surgery depends upon the size of the tumor and its position within the lung.
| By Type | ||||||
| ||||||
| Minimally Invasive Surgeries |
| By Product | |
| Surgical Devices | |
| Monitoring Devices |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Lung Cancer Surgery Market Size Summary
The lung cancer surgery market is experiencing growth driven by increasing air pollution and its impact on lung cancer rates. The prevalence of lung cancer is rising, particularly in highly polluted areas like India, where air quality issues contribute significantly to respiratory diseases. Technological advancements in early-stage treatment options are further propelling market expansion. Surgical techniques such as segmentectomy are gaining popularity due to their favorable outcomes, including reduced pain and quicker recovery compared to traditional methods. This technique is particularly beneficial for patients with limited lung capacity, offering higher survival rates and better organ function retention, which is expected to enhance market growth.
In the United States, the lung cancer surgery market is bolstered by a significant number of diagnosed cases and improved survival rates, particularly for non-small cell lung cancer. The demand for cancer treatment is high, driven by the aging population and the burden of the disease. The market is moderately competitive, with major players holding significant shares, yet technological innovations and cost-effective product offerings from mid-size and smaller companies are increasing their market presence. Key players in the market include Accuray Incorporated, GE Healthcare, Johnson and Johnson, Olympus Corporation, and Siemens Healthineers AG, all contributing to the dynamic landscape of the lung cancer surgery market.
Lung Cancer Surgery Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Growing Burden of Lung Cancer
-
1.2.2 Technological Advancements in the Field of Minimally Invasive Surgeries
-
1.2.3 Rise in the Level of Air Pollution
-
-
1.3 Market Restraints
-
1.3.1 Effective Alternative Treatment
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 By Type
-
2.1.1 Thoracotomy
-
2.1.1.1 Lobectomy
-
2.1.1.2 Sleeve Resection
-
2.1.1.3 Segmentectomy
-
2.1.1.4 Pneumonectomy
-
-
2.1.2 Minimally Invasive Surgeries
-
-
2.2 By Product
-
2.2.1 Surgical Devices
-
2.2.2 Monitoring Devices
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 United Kingdom
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia-Pacific
-
2.3.3.1 China
-
2.3.3.2 Japan
-
2.3.3.3 India
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia-Pacific
-
-
2.3.4 Middle-East and Africa
-
2.3.4.1 GCC
-
2.3.4.2 South Africa
-
2.3.4.3 Rest of Middle-East and Africa
-
-
2.3.5 South America
-
2.3.5.1 Brazil
-
2.3.5.2 Argentina
-
2.3.5.3 Rest of South America
-
-
-
Lung Cancer Surgery Market Size FAQs
What is the current Lung Cancer Surgery Market size?
The Lung Cancer Surgery Market is projected to register a CAGR of 7% during the forecast period (2024-2029)
Who are the key players in Lung Cancer Surgery Market?
Accuray Incorporated, GE Healthcare, Johnson and Johnson, Olympus Corporation and Siemens Healthineers AG are the major companies operating in the Lung Cancer Surgery Market.
